Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 6 | 2024 | 584 | 2.930 |
Why?
|
| Brazil | 22 | 2025 | 88 | 1.840 |
Why?
|
| Health Services Accessibility | 9 | 2024 | 527 | 1.630 |
Why?
|
| Early Detection of Cancer | 3 | 2024 | 266 | 1.550 |
Why?
|
| Antihypertensive Agents | 4 | 2019 | 162 | 1.260 |
Why?
|
| Health Expenditures | 3 | 2020 | 116 | 1.100 |
Why?
|
| Cost Sharing | 4 | 2020 | 14 | 1.010 |
Why?
|
| Diabetes Mellitus | 6 | 2022 | 515 | 1.000 |
Why?
|
| Socioeconomic Factors | 4 | 2024 | 742 | 0.900 |
Why?
|
| Pharmaceutical Services | 3 | 2018 | 31 | 0.800 |
Why?
|
| Interrupted Time Series Analysis | 6 | 2022 | 28 | 0.740 |
Why?
|
| Hypoglycemic Agents | 3 | 2019 | 192 | 0.720 |
Why?
|
| Commerce | 2 | 2019 | 53 | 0.700 |
Why?
|
| Health Policy | 4 | 2019 | 177 | 0.700 |
Why?
|
| Drug Costs | 3 | 2017 | 54 | 0.700 |
Why?
|
| Hypertension | 4 | 2020 | 568 | 0.680 |
Why?
|
| Financing, Government | 1 | 2020 | 30 | 0.660 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 1507 | 0.660 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 98 | 0.650 |
Why?
|
| Smoking | 1 | 2024 | 826 | 0.630 |
Why?
|
| Retrospective Studies | 13 | 2025 | 6070 | 0.620 |
Why?
|
| Pharmaceutical Preparations | 3 | 2015 | 117 | 0.610 |
Why?
|
| Drug Prescriptions | 2 | 2025 | 168 | 0.610 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 25 | 0.560 |
Why?
|
| Drug Industry | 1 | 2017 | 39 | 0.550 |
Why?
|
| Incidence | 5 | 2025 | 1238 | 0.490 |
Why?
|
| Education, Continuing | 1 | 2014 | 23 | 0.450 |
Why?
|
| Capacity Building | 1 | 2014 | 21 | 0.450 |
Why?
|
| Insurance, Health | 1 | 2015 | 144 | 0.450 |
Why?
|
| Education, Distance | 1 | 2014 | 34 | 0.440 |
Why?
|
| Humans | 32 | 2025 | 59374 | 0.440 |
Why?
|
| National Health Programs | 4 | 2019 | 13 | 0.420 |
Why?
|
| Medication Adherence | 1 | 2015 | 241 | 0.420 |
Why?
|
| Delivery of Health Care | 3 | 2022 | 411 | 0.410 |
Why?
|
| Female | 15 | 2025 | 30720 | 0.380 |
Why?
|
| Acute Disease | 1 | 2013 | 658 | 0.380 |
Why?
|
| Aged | 10 | 2025 | 13406 | 0.370 |
Why?
|
| Health Personnel | 1 | 2014 | 342 | 0.350 |
Why?
|
| Male | 13 | 2025 | 27743 | 0.340 |
Why?
|
| Middle Aged | 12 | 2025 | 16312 | 0.340 |
Why?
|
| Primary Health Care | 2 | 2022 | 647 | 0.340 |
Why?
|
| Malaria | 1 | 2011 | 101 | 0.330 |
Why?
|
| Risk Factors | 5 | 2024 | 4986 | 0.300 |
Why?
|
| Drugs, Essential | 2 | 2018 | 2 | 0.300 |
Why?
|
| Pandemics | 2 | 2025 | 616 | 0.290 |
Why?
|
| Adult | 8 | 2025 | 15679 | 0.290 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 551 | 0.280 |
Why?
|
| Drugs, Generic | 3 | 2019 | 16 | 0.270 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1189 | 0.270 |
Why?
|
| Honduras | 3 | 2015 | 3 | 0.270 |
Why?
|
| Guatemala | 3 | 2015 | 4 | 0.270 |
Why?
|
| Nicaragua | 3 | 2015 | 16 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 725 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 2379 | 0.250 |
Why?
|
| Prevalence | 3 | 2024 | 1252 | 0.240 |
Why?
|
| Politics | 1 | 2025 | 32 | 0.240 |
Why?
|
| Databases, Factual | 2 | 2025 | 814 | 0.220 |
Why?
|
| Anastomotic Leak | 1 | 2024 | 33 | 0.220 |
Why?
|
| Chronic Disease | 2 | 2018 | 717 | 0.220 |
Why?
|
| Sex Distribution | 1 | 2024 | 244 | 0.220 |
Why?
|
| Age Distribution | 1 | 2024 | 249 | 0.220 |
Why?
|
| Esophagectomy | 1 | 2024 | 47 | 0.220 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 79 | 0.210 |
Why?
|
| Fees, Pharmaceutical | 2 | 2015 | 5 | 0.210 |
Why?
|
| Smokers | 1 | 2023 | 116 | 0.200 |
Why?
|
| Acinetobacter baumannii | 1 | 2022 | 4 | 0.200 |
Why?
|
| Acinetobacter Infections | 1 | 2022 | 5 | 0.200 |
Why?
|
| Robotics | 1 | 2022 | 69 | 0.180 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2023 | 96 | 0.180 |
Why?
|
| Tuberculosis | 1 | 2024 | 270 | 0.180 |
Why?
|
| Thoracic Surgery | 1 | 2022 | 68 | 0.180 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 31 | 0.180 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 135 | 0.180 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 153 | 0.180 |
Why?
|
| Program Evaluation | 2 | 2020 | 470 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 396 | 0.180 |
Why?
|
| Life Expectancy | 1 | 2020 | 34 | 0.180 |
Why?
|
| Frailty | 1 | 2022 | 124 | 0.170 |
Why?
|
| Registries | 1 | 2024 | 799 | 0.170 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 448 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 1 | 2023 | 170 | 0.170 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 330 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 98 | 0.170 |
Why?
|
| Government Programs | 1 | 2020 | 20 | 0.170 |
Why?
|
| Community Pharmacy Services | 1 | 2019 | 13 | 0.170 |
Why?
|
| Robotic Surgical Procedures | 1 | 2022 | 115 | 0.160 |
Why?
|
| Quality Improvement | 1 | 2024 | 417 | 0.160 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 902 | 0.160 |
Why?
|
| Young Adult | 3 | 2025 | 4272 | 0.160 |
Why?
|
| Public Health | 1 | 2021 | 176 | 0.160 |
Why?
|
| Mass Screening | 1 | 2024 | 648 | 0.160 |
Why?
|
| Longevity | 1 | 2019 | 110 | 0.150 |
Why?
|
| Quality of Health Care | 1 | 2022 | 513 | 0.140 |
Why?
|
| Losartan | 1 | 2017 | 18 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 192 | 0.140 |
Why?
|
| Renin-Angiotensin System | 1 | 2017 | 21 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 205 | 0.140 |
Why?
|
| Medicare | 1 | 2021 | 601 | 0.140 |
Why?
|
| Linear Models | 1 | 2017 | 403 | 0.130 |
Why?
|
| Lung | 1 | 2021 | 920 | 0.130 |
Why?
|
| Drug and Narcotic Control | 1 | 2015 | 28 | 0.120 |
Why?
|
| Americas | 1 | 2014 | 5 | 0.120 |
Why?
|
| Professional Competence | 1 | 2014 | 91 | 0.110 |
Why?
|
| Public Sector | 2 | 2010 | 13 | 0.100 |
Why?
|
| Private Sector | 2 | 2010 | 12 | 0.100 |
Why?
|
| Research | 1 | 2014 | 188 | 0.100 |
Why?
|
| Income | 1 | 2013 | 157 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 277 | 0.100 |
Why?
|
| United States | 2 | 2024 | 7425 | 0.100 |
Why?
|
| Quality of Life | 1 | 2019 | 1137 | 0.100 |
Why?
|
| Cities | 2 | 2021 | 23 | 0.090 |
Why?
|
| Sex Factors | 1 | 2013 | 935 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 5119 | 0.090 |
Why?
|
| World Health Organization | 1 | 2009 | 30 | 0.080 |
Why?
|
| Adolescent | 2 | 2025 | 5835 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2024 | 1925 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 332 | 0.060 |
Why?
|
| Ivermectin | 1 | 2025 | 11 | 0.060 |
Why?
|
| Chloroquine | 1 | 2025 | 50 | 0.060 |
Why?
|
| Hydroxychloroquine | 1 | 2025 | 19 | 0.060 |
Why?
|
| Azithromycin | 1 | 2025 | 27 | 0.060 |
Why?
|
| Time Factors | 2 | 2025 | 3615 | 0.060 |
Why?
|
| Outpatients | 1 | 2025 | 137 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2025 | 486 | 0.060 |
Why?
|
| Stomach | 1 | 2024 | 83 | 0.050 |
Why?
|
| Portugal | 1 | 2023 | 3 | 0.050 |
Why?
|
| State Medicine | 1 | 2023 | 9 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2023 | 7 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 113 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2022 | 112 | 0.050 |
Why?
|
| Emergencies | 1 | 2022 | 110 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2025 | 1283 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1234 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 454 | 0.040 |
Why?
|
| Health Services | 1 | 2021 | 81 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2020 | 59 | 0.040 |
Why?
|
| Infant | 1 | 2025 | 1491 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 377 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2025 | 1792 | 0.040 |
Why?
|
| Pharmacies | 1 | 2019 | 34 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2022 | 327 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 326 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 166 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2022 | 423 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2022 | 682 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2019 | 202 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2014 | 2516 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2022 | 1204 | 0.030 |
Why?
|
| Child | 1 | 2025 | 4186 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2015 | 42 | 0.030 |
Why?
|
| Suriname | 1 | 2014 | 1 | 0.030 |
Why?
|
| El Salvador | 1 | 2014 | 4 | 0.030 |
Why?
|
| Colombia | 1 | 2014 | 17 | 0.030 |
Why?
|
| Dominican Republic | 1 | 2014 | 21 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 79 | 0.030 |
Why?
|
| Health Services Research | 1 | 2014 | 266 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5281 | 0.020 |
Why?
|